Buscar
Mostrando ítems 21-30 de 137
Oral moxifloxacin in the outpatient treatment of low-risk children with fever and neutropenia
(Elsevier B.V., 2008-06-01)
A phase 2 randomized trial of a rifapentine plus moxifloxacin-based regimen for treatment of pulmonary tuberculosis
(Public Library of Science, 2016)
Average Bioequivalence Of Single 500 Mg Doses Of Two Oral Formulations Of Levofloxacin: A Randomized, Open-label, Two-period Crossover Study In Healthy Adult Brazilian Volunteers
(UNIV SAO PAULO, CONJUNTO QUIMICASSAO PAULO, 2015)
In vitro antibiotic susceptibilities of ocular bacteria isolates from the cornea and conjunctiva to moxifloxacin, gatifloxacin and other fluoroquinolones
(Conselho Brasileiro de Oftalmologia, 2004-12-01)
PURPOSE: To assess and compare the in vitro susceptibility of ocular bacterial isolates to fluoroquinolones, including moxifloxacin and gatifloxacin. METHODS: A total of 154 bacterial ocular isolates from keratitis and ...
Perfil de sensibilidade antimicrobiana de Clostridioides (Clostridium) difficile ao metronidazol, vancomicina e moxifloxacina isolados de animais e seres humanos em Minas Gerais, Brasil
(Universidade Federal de Minas GeraisBrasilVET - DEPARTAMENTO DE MEDICINA VETERINÁRIA PREVENTIVAPrograma de Pós-Graduação em Ciência AnimalUFMG, 2021-01-25)
Clostridioides difficile is a bacterial enteropathogen that infects animals and humans, able to
promote intestinal disorders that can lead to its host's death. Infection with C. difficile (CDI)
currently represents one ...
Second-line drug susceptibility breakpoints for Mycobacterium tuberculosis using the MODS assay
(International Union Against Tuberculosis and Lung Disease, 2014)
OBJECTIVE: To establish breakpoint concentrations for the fluoroquinolones (moxifloxacin [MFX] and ofloxacin [OFX]) and injectable second-line drugs (amikacin [AMK], kanamycin [KM] and capreomycin [CPM]) using the microscopic ...